Vir Biotechnology Inc.

NASDAQ: VIR · Real-Time Price · USD
4.51
0.07 (1.58%)
At close: Aug 15, 2025, 3:59 PM
4.49
-0.43%
After-hours: Aug 15, 2025, 07:24 PM EDT

Vir Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-550.23M -577.65M -521.96M -533.34M -483.04M -539.44M -615.12M -600.75M -262.02M -143.74M 515.84M 1.14B 1.08B 1.22B 528.58M -102.32M -297.36M -390.34M
Depreciation & Amortization
18.18M 12.91M 14.56M 16.15M 17.84M 18.33M 19.45M 16.93M 14.02M 10.87M 6.78M 6.35M 6.16M 5.96M 5.81M 5.63M 5.57M 5.54M
Stock-Based Compensation
59.05M 68.76M 78.46M 90.89M 101.14M 109.59M 111.32M 107.91M 105.78M 102.26M 102.08M 101.59M 99.72M 93.62M 83.78M 69.71M 55.35M 40.1M
Other Working Capital
10.36M 35.68M -74.27M -348.04M -386.88M -386.27M -301.72M -172.78M -259.35M -259.83M 188.26M 341.89M 366.4M 418.71M -14.01M 11.31M 99.34M 61.49M
Other Non-Cash Items
17.79M 90.67M 132.89M 124.13M 291.4M 232.38M 163.5M 149.67M -51.61M 348.95M 376.32M 433.35M 476.4M 67.1M 112.37M 46.1M 49.46M 64.51M
Deferred Income Tax
-2.59M -2.95M -2.95M -1.37M -168.05M -153.34M -153.34M -167.46M -836K -15.19M -15.19M 15.19M -149.51M -150.15M -149.75M -164.98M 776K 1.68M
Change in Working Capital
492K 24.2M -84.01M -99.75M -146.94M -397.46M -304.59M -142.03M -167.33M 672.18M 665.37M -75.4M -110.52M -640.62M -628.39M 8.52M 104.83M 46.44M
Operating Cash Flow
-457.45M -415.08M -446.35M -466.64M -450.99M -762.39M -778.78M -635.73M -362M 987.38M 1.66B 1.64B 1.41B 592.03M -47.59M -137.34M -81.36M -232.06M
Capital Expenditures
-8.93M -7.06M -7.3M -6.43M -7.79M -16.58M -21.57M -32.63M -47.91M -59.05M -68.03M -68.5M -55.51M -36.99M -21.82M -11.18M -6.65M -5.91M
Cash Acquisitions
-912K -533K n/a 184.43M 240.58M 433K n/a -43.89M -99.12M 140.65M 140.56M 18K 11K 12K n/a 4K n/a n/a
Purchase of Investments
-767.07M -846.09M -1.24B -1.89B -2.16B -2.19B -2.02B -1.6B -1.83B -1.77B -1.48B -1.43B -705.8M -504.8M -420.24M -96.17M -329.67M -368.37M
Sales Maturities Of Investments
1.22B 1.45B 1.74B 2.15B 2.24B 2.31B 2.2B 1.75B 1.39B 840.97M 351.51M 84.84M 79.86M 208.04M 301.24M 404.83M 374.56M 347.74M
Other Investing Acitivies
3.7M 215.93M 216.18M 28.88M -26.87M 633K n/a 43.89M -544.48M -1.04B -1.04B -895.34M -251.72M 77.46M 165.65M 228.8M 44.89M -20.63M
Investing Cash Flow
442.61M 597.76M 499.37M 253.82M 76.26M 94.97M 164.63M 116.31M -487.35M -989.99M -1.19B -1.42B -681.44M -333.74M -140.81M 297.48M 38.24M -26.55M
Debt Repayment
-40K -109K -178K -178K -138K -137K -134K -211K -270K -262K -260K -255K -257K -261K -259K -264K -261K -254K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a 3.22M 3.22M 3.22M 3.22M 2.3M 2.3M 2.3M 2.3M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.22M 4.94M 4.57M 4.98M 5.19M 5.42M 7.61M 8.02M 9.79M 9.68M 6.56M 10.21M 11.86M 12.31M 15.38M 9.45M 6.92M 2.02M
Financial Cash Flow
3.94M 4.83M 4.39M 4.8M 5.05M 5.29M 7.48M 7.81M 9.52M 9.42M 34.76M 38.42M 40.06M 40.51M 100.33M 94.4M 415.08M 616.89M
Net Cash Flow
-4.53M 193.95M 63.85M -200.96M -368.99M -661.51M -606.07M -511.62M -839.83M 6.81M 504.55M 256.33M 770.73M 298.8M -88.07M 254.55M 371.96M 358.28M
Free Cash Flow
-466.38M -422.14M -453.65M -473.07M -458.78M -778.97M -800.36M -668.37M -409.91M 928.33M 1.6B 1.57B 1.36B 555.04M -69.41M -148.52M -88.01M -237.97M